Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1947 1
1969 1
1977 1
1979 4
1980 1
1981 2
1982 4
1984 2
1985 8
1986 4
1987 7
1988 8
1989 1
1990 7
1991 6
1992 1
1993 6
1994 5
1995 4
1996 1
1997 3
1998 3
1999 5
2000 2
2001 2
2002 2
2003 2
2004 1
2005 1
2006 1
2007 3
2008 3
2009 4
2010 3
2011 6
2012 6
2013 6
2014 14
2015 16
2016 16
2017 20
2018 16
2019 17
2020 13
2021 20
2022 16
2023 10
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

261 results

Results by year

Filters applied: . Clear all
Page 1
Treatment of AL Amyloidosis: Mayo Stratification of Myeloma and Risk-Adapted Therapy (mSMART) Consensus Statement 2020 Update.
Muchtar E, Dispenzieri A, Gertz MA, Kumar SK, Buadi FK, Leung N, Lacy MQ, Dingli D, Ailawadhi S, Bergsagel PL, Fonseca R, Hayman SR, Kapoor P, Grogan M, Abou Ezzeddine OF, Rosenthal JL, Mauermann M, Siddiqui M, Gonsalves WI, Kourelis TV, Larsen JT, Reeder CB, Warsame R, Go RS, Murray DL, McPhail ED, Dasari S, Jevremovic D, Kyle RA, Lin Y, Lust JA, Russell SJ, Hwa YL, Fonder AL, Hobbs MA, Rajkumar SV, Roy V, Sher T. Muchtar E, et al. Among authors: murray dl. Mayo Clin Proc. 2021 Jun;96(6):1546-1577. doi: 10.1016/j.mayocp.2021.03.012. Mayo Clin Proc. 2021. PMID: 34088417 Review.
Commentary.
Murray DL. Murray DL. Clin Chem. 2019 Jul;65(7):837-838. doi: 10.1373/clinchem.2019.302901. Clin Chem. 2019. PMID: 31253609 No abstract available.
Cryofibrinogen-Associated Glomerulonephritis.
Sethi S, Yachoui R, Murray DL, Radhakrishnan J, Alexander MP. Sethi S, et al. Among authors: murray dl. Am J Kidney Dis. 2017 Feb;69(2):302-308. doi: 10.1053/j.ajkd.2016.08.031. Epub 2016 Nov 17. Am J Kidney Dis. 2017. PMID: 27866967
Response.
McDonald RJ, McDonald JS, Kallmes DF, Jentoft ME, Murray DL, Thielen KR, Williamson EE, Eckel LJ. McDonald RJ, et al. Among authors: murray dl. Radiology. 2015 Dec;277(3):925. Radiology. 2015. PMID: 26929976 No abstract available.
Cefaclor reactions.
Murray DL. Murray DL. Pediatr Infect Dis. 1985 Nov-Dec;4(6):706. doi: 10.1097/00006454-198511000-00038. Pediatr Infect Dis. 1985. PMID: 4080599 No abstract available.
Rabies.
Mani CS, Murray DL. Mani CS, et al. Among authors: murray dl. Pediatr Rev. 2006 Apr;27(4):129-36; quiz 136. doi: 10.1542/pir.27-4-129. Pediatr Rev. 2006. PMID: 16581953 No abstract available.
Monitoring Ravulizumab effect on complement assays.
Willrich MAV, Ladwig PM, Martinez MA, Sridharan MR, Go RS, Murray DL; Complement Alternative Pathway Thrombotic Microangiopathy (CAP-TMA) Disease Oriented Group at the Mayo Clinic. Willrich MAV, et al. Among authors: murray dl. J Immunol Methods. 2021 Mar;490:112944. doi: 10.1016/j.jim.2020.112944. Epub 2020 Dec 13. J Immunol Methods. 2021. PMID: 33321132
261 results